Risultati per: Linee guida su HIV, epatite e malattie sessualmente trasmissibili.

Coinvolti Austria, Repubblica Ceca, Ungheria e Slovacchia

Ma è vero che l’Aids si trasmette con un bacio? E le zanzare possono infettarmi? Cosa rischio se condivido una bibita? Sono alcune delle domande che ancora oggi sono rivolte…

La Food and Drug Administration (Fda) statunitense ha approvato lenacapavir (Yeztugo), un nuovo farmaco che promette una protezione quasi totale contro l’Hiv con una semplice iniezione ogni sei mesi. È…

Siglato alla 20/ma convention Greenvision in corso in Sicilia

‘Mancanza tempo? Patologie abbiano precedenza su altri impegni’

Terapia orale iptacopan per emoglobinuria parossistica notturna

Annals of Internal Medicine, Ahead of Print.

Integrase inhibitor–based regimens are recommended for 28 days after nonoccupational exposures.

Pubblicate su Annals of Rheumatic Diseases nuove raccomandazioni

Introduction
HIV and tuberculosis (TB) are two of the most devastating disease conditions of public health concern globally. A co-infection of the two diseases poses serious health challenges to patients including mental health problems, ranging from mild to severe, with differing outcomes. This systematic review aims to assess the correlates of HIV-TB co-infection and mental health of adults living in sub-Saharan Africa.

Methods and analysis
We will conduct comprehensive database and non-database searches for studies (published and unpublished). We will search Google Scholar, PubMed, CINAHL, LILACS, JSTOR, Cochrane Library, SCOPUS, PsycINFO, HINARI and African Journals Online from inception to 31 May 2025, without restriction on language. We will also search the grey literature, including conference proceedings, preprint repositories, databases of dissertations, WHO and governmental databases. In the event where there is a need to contact experts and corresponding authors for further information, the review team will do so to enrich the content of the review. At least three reviewers will independently undertake study selection, data extraction and risk of bias assessment using validated tools. We will resolve discrepancies or disagreements through discussion. We will analyse dichotomous data as risk ratio, OR or proportion and continuous data as mean difference with their SD; all estimates will be presented with their 95% CI. Where applicable, we will determine SD from point estimates and the appropriate denominators assuming a binomial distribution. The magnitude of heterogeneity between the included studies will be assessed quantitatively using the index of heterogeneity (I2 statistic). The I2 values of 25%, 50% and 75% will be considered to represent low, moderate and significant heterogeneity. The significance of heterogeneity will be determined by the p value of the I2 statistic, and a p value of

Gruppo di lavoro per garantire uniformità e solidità scientifica

A new guideline calls for broader use of statins in this population.

Al San Matteo di Pavia, per beta talassemia e anemia falciforme

Al Policlinico San Matteo di Pavia su due ragazze ventenni